NBIX
$165.92+0.37%
as of close, Nov 17, 2026
☾ AH $165.92 +0.37%
Neurocrine Biosciences Inc.Stock · HealthcareNasdaq Composite · 0.03% of ONEQRussell 1000 · 0.02% of IWBUS Stock Market · 0.02% of VTIRussell 3000 · 0.02% of IWVMSCI ACWI · 0.02% of ACWIMSCI World · 0.02% of URTH
Head-to-head:Compare with UTHR or any ticker →
Neurocrine Biosciences Inc. total returns by year (including dividends)
As of market close, Nov 17, 2026
Every year since 1996#
Data provided bySource: Twelve DataCalendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start | End | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $141.83 | $165.92 | 0.0% | +17.0% | |
| 2025 | $136.50 | $141.83 | 0.0% | +3.9% | |
| 2024 | $131.76 | $136.50 | 0.0% | +3.6% | |
| 2023 | $119.44 | $131.76 | 0.0% | +10.3% | |
| 2022 | $85.17 | $119.44 | 0.0% | +40.2% | |
| 2021 | $95.85 | $85.17 | 0.0% | -11.1% | |
| 2020 | $107.49 | $95.85 | 0.0% | -10.8% | |
| 2019 | $71.41 | $107.49 | 0.0% | +50.5% | |
| 2018 | $77.59 | $71.41 | 0.0% | -8.0% | |
| 2017 | $38.70 | $77.59 | 0.0% | +100.5% | |
| 2016 | $56.57 | $38.70 | 0.0% | -31.6% | |
| 2015 | $22.34 | $56.57 | 0.0% | +153.2% | |
| 2014 | $9.34 | $22.34 | 0.0% | +139.2% | |
| 2013 | $7.48 | $9.34 | 0.0% | +24.9% | |
| 2012 | $8.50 | $7.48 | 0.0% | -12.0% | |
| 2011 | $7.64 | $8.50 | 0.0% | +11.3% | |
| 2010 | $2.72 | $7.64 | 0.0% | +180.9% | |
| 2009 | $3.20 | $2.72 | 0.0% | -15.0% | |
| 2008 | $4.54 | $3.20 | 0.0% | -29.5% | |
| 2007 | $10.42 | $4.54 | 0.0% | -56.4% | |
| 2006 | $62.73 | $10.42 | 0.0% | -83.4% | |
| 2005 | $49.30 | $62.73 | 0.0% | +27.2% | |
| 2004 | $54.54 | $49.30 | 0.0% | -9.6% | |
| 2003 | $45.66 | $54.54 | 0.0% | +19.4% | |
| 2002 | $51.31 | $45.66 | 0.0% | -11.0% | |
| 2001 | $33.13 | $51.31 | 0.0% | +54.9% | |
| 2000 | $24.75 | $33.13 | 0.0% | +33.8% | |
| 1999 | $6.88 | $24.75 | 0.0% | +260.0% | |
| 1998 | $7.88 | $6.88 | 0.0% | -12.7% | |
| 1997 | $10.00 | $7.88 | 0.0% | -21.3% | |
| 1996since May 23 | $12.50 | $10.00 | 0.0% | -20.0% |
- Annualized
- +9.3%
- 1997–2026
- Average year
- +27.6%
- 29 full years
- Best year
- +260.0%
- 1999
- Worst year
- -83.4%
- 2006
- Positive years
- 16/29
- 55% up
Annualized (CAGR)
+9.3%
1997–2026
Average year
+27.6%
29 full years
Best year
+260.0%
1999
Worst year
-83.4%
2006
Positive years
16/29
55% up
Total return by period#
Annual
−300%−200%−100%0%100%200%300%
1996, since May 23-20%'96
1997-21%
1998-13%
1999+260%'99
2000+34%
2001+55%
2002-11%'02
2003+19%
2004-9.6%
2005+27%'05
2006-83%
2007-56%
2008-30%'08
2009-15%
2010+181%
2011+11%'11
2012-12%
2013+25%
2014+139%'14
2015+153%
2016-32%
2017+100%'17
2018-8.0%
2019+51%
2020-11%'20
2021-11%
2022+40%
2023+10%'23
2024+3.6%
2025+3.9%
2026+17%'26
Methodology#
Total returns, dividends reinvested, measured on NBIX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Neurocrine Biosciences Inc.'s average annual return?
- Since 1997, Neurocrine Biosciences Inc. (NBIX) has returned about 9.3% a year (the compound annual growth rate) and an average calendar-year return of 27.6%.
- What were Neurocrine Biosciences Inc.'s best and worst years?
- Over 1997–2026, the best year was 1999 (+260.0%) and the worst was 2006 (-83.4%).
- How often is Neurocrine Biosciences Inc. up in a year?
- 16 of the 29 full years since 1997 were positive — about 55% of the time.
More on Neurocrine Biosciences Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100
Head-to-head:Compare with UTHR or any ticker →
